0001437749-16-032596.txt : 20160520
0001437749-16-032596.hdr.sgml : 20160520
20160520173417
ACCESSION NUMBER: 0001437749-16-032596
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160516
FILED AS OF DATE: 20160520
DATE AS OF CHANGE: 20160520
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Diffusion Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001053691
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300645032
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2020 AVON COURT
STREET 2: SUITE 4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
BUSINESS PHONE: (434) 220-0718
MAIL ADDRESS:
STREET 1: 2020 AVON COURT
STREET 2: SUITE 4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
FORMER COMPANY:
FORMER CONFORMED NAME: RestorGenex Corp
DATE OF NAME CHANGE: 20140307
FORMER COMPANY:
FORMER CONFORMED NAME: Stratus Media Group, Inc
DATE OF NAME CHANGE: 20080722
FORMER COMPANY:
FORMER CONFORMED NAME: FERIS INTERNATIONAL, INC.
DATE OF NAME CHANGE: 20080228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Byrne Thomas E
CENTRAL INDEX KEY: 0001663220
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24477
FILM NUMBER: 161667356
MAIL ADDRESS:
STREET 1: 2020 AVON COURT
STREET 2: SUITE 4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
FORMER NAME:
FORMER CONFORMED NAME: Byrne Thomas S
DATE OF NAME CHANGE: 20160108
4
1
rdgdoc.xml
FORM 4
X0306
4
2016-05-16
0001053691
Diffusion Pharmaceuticals Inc.
DFFN
0001663220
Byrne Thomas E
2020 AVON COURT, SUITE 4
CHARLOTTESVILLE
VA
22902
1
General Counsel
Stock Option (Right to Buy)
0.96
2016-05-16
4
A
0
16667
0
A
2026-05-16
Common Stock
16667
16667
D
The shares underlying the options vest in equal parts each month until fully vested on the third anniversary of the grant date.
/s/ Ben Shealy, attorney-in-fact for Thomas Byrne
2016-05-20